Lv3
360 积分 2024-09-18 加入
SAT0397 Safety and immunogenicity of 23-valent pneumococcal vaccine in sle patients
24天前
已完结
SAT0394 Immunogenicity and safety of 23-valent pneumococcal vaccine in ra patients: results of a 4- year follow up study
24天前
已关闭
THU0149 PRIME-BOOSTER RESPONSE TO PNEUMOCOCCAL CONJUGATE AND POLYSACCHARIDE VACCINES IN PATIENTS WITH INFLAMMATORY RHEUMATIC DISEASES
24天前
已完结
THU0127 IMMUNOGENICITY AND SAFETY OF 23-VALENT PNEUMOCOCCAL VACCINE IN PATIENTS WITH RHEUMATOID ARTHRITIS: RESULTS FROM 5-YEAR FOLLOW UP
24天前
已完结
AB0542 REACTIONS TO PNEUMOCOCCAL 13-VALENT VACCINE IN PATIENTS WITH BEHCET SYNDROME
24天前
已完结
THU0563 IMMUNOGENICITY AND SAFETY OF 23-VALENT PNEUMOCOCCAL VACCINE IN PATIENTS WITH ANKYLOSING SPONDYLITIS (PRELIMINARY RESULTS)
24天前
已完结
AB0500 Tolerability, efficacy and immunogenicity of 23-valent pneumococcal vaccine in sle patients
24天前
已完结
THU0132 Immunogenicity and safety of 23-valent pneumococcal vaccine for patients with rheumatoid arthritis: results from 2-year follow up
24天前
已关闭
AB0804 ONE YEAR FOLLOW-UP SAFETY AND EFFICACY RESULTS OF VACCINATION PROTOCOL FROM A RHEUMATOLOGY CLINIC
24天前
已完结
AB0310 TOLERABILITY AND SAFETY OF 23-VALENT POLYSACCHARIDE PNEUMOCOCCAL VACCINE IN PATIENTS WITH ANTIPHOSPHOLIPID SYNDROME, PRELIMINARY RESULTS
24天前
已完结
皖公网安备34019202002308
